Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
320.53
-22.05 (-6.44%)
May 18, 2026, 4:00 PM EDT - Market closed
Praxis Precision Medicines Employees
Praxis Precision Medicines had 168 employees as of December 31, 2025. The number of employees increased by 52 or 44.83% compared to the previous year.
Employees
168
Change (1Y)
52
Growth (1Y)
44.83%
Revenue / Employee
n/a
Profits / Employee
-$1,943,649
Market Cap
8.94B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 168 | 52 | 44.83% | 168 | 0 |
| Dec 31, 2024 | 116 | 34 | 41.46% | 116 | 0 |
| Dec 31, 2023 | 82 | -27 | -24.77% | 82 | 0 |
| Dec 31, 2022 | 109 | -30 | -21.58% | 109 | 0 |
| Dec 31, 2021 | 139 | 72 | 107.46% | 139 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BioMarin Pharmaceutical | 3,221 |
| Axsome Therapeutics | 1,220 |
| Madrigal Pharmaceuticals | 915 |
| Arrowhead Pharmaceuticals | 711 |
| ImmunityBio | 691 |
| Cytokinetics | 673 |
| Vaxcyte | 507 |
| Halozyme Therapeutics | 423 |
PRAX News
- 5 days ago - Praxis Precision assumed with a Buy at Truist - TheFly
- 6 days ago - Praxis Precision Medicines Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 10 days ago - Praxis Precision price target lowered to $420 from $444 at Deutsche Bank - TheFly
- 10 days ago - Praxis Precision price target raised to $166 from $130 at Wedbush - TheFly
- 11 days ago - Praxis Precision Medicines Earnings Call Transcript: Q1 2026 - Transcripts
- 11 days ago - Praxis Precision Medicines Earnings release: Q1 2026 - Filings
- 11 days ago - Praxis Precision Medicines Quarterly report: Q1 2026 - Filings
- 11 days ago - Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2026 Financial Results - GlobeNewsWire